.Alnylam is suspending even further advancement of a clinical-stage RNAi healing designed to allevia...
.Takeda has actually quit (PDF) a phase 2 test of danavorexton due to sluggish registration, marking...
.Compass Pathways' quest to period 3 experimental anxiety records is taking much longer than anticip...
.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer in 2015 for...
.On the heels of a period 3 win that fell short to excite real estate investors, Ironwood Pharmaceut...
.Don't cease Monte Rosa Rehabs now. The Boston-based biotech is having a ball after signing a manage...
.Accept to this week's Chutes & Ladders, our summary of significant leadership hirings, shootings...
.Commemorating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer call...
.AbbVie has come back to the source of its own antipsychotic giant Vraylar seeking one more runaway ...
.GenSight Biologics is actually weeks off of losing loan. Once again. The biotech only has adequate ...